Hangzhou Tigermed Consulting Co., Ltd. Class H (DE:5HZ1)
FRANKFURT:5HZ1
Total Valuation
Hangzhou Tigermed Consulting Co., Ltd. Class H has a market cap or net worth of €5.43B. The enterprise value is €42.39B.
Market Cap€5.43B
Enterprise Value€42.39B
Share Statistics
Hangzhou Tigermed Consulting Co., Ltd. Class H has 123,124,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding123,124,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Hangzhou Tigermed Consulting Co., Ltd. Class H’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 3.11%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)3.11%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee670.87K
Profits Per Employee79.04K
Employee Count10,185
Asset Turnover0.24
Inventory Turnover119.50
Valuation Ratios
The current PE Ratio of Hangzhou Tigermed Consulting Co., Ltd. Class H is 37.1. Hangzhou Tigermed Consulting Co., Ltd. Class H’s PEG ratio is 0.31.
PE Ratio37.1
PS Ratio4.81
PB Ratio1.57
Price to Fair Value1.57
Price to FCF36.40
Price to Operating Cash Flow39.13
PEG Ratio0.31
Income Statement
In the last 12 months, Hangzhou Tigermed Consulting Co., Ltd. Class H had revenue of 6.83B and earned 887.89M in profits. Earnings per share was 1.03.
Revenue6.83B
Gross Profit1.87B
Operating Income1.01B
Pretax Income1.00B
Net Income887.89M
EBITDA1.42B
Earnings Per Share (EPS)1.03
Cash Flow
In the last 12 months, operating cash flow was 1.27B and capital expenditures -215.62M, giving a free cash flow of 1.05B billion.
Operating Cash Flow1.27B
Free Cash Flow1.05B
Free Cash Flow per Share8.55
Dividends & Yields
Hangzhou Tigermed Consulting Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.69
52-Week Price Change53.28%
50-Day Moving Average4.93
200-Day Moving Average4.97
Relative Strength Index (RSI)45.39
Average Volume (3m)6.00
Important Dates
Hangzhou Tigermed Consulting Co., Ltd. Class H upcoming earnings date is Apr 29, 2026, TBA (Not Confirmed).
Last Earnings DateMar 30, 2026
Next Earnings DateApr 29, 2026
Ex-Dividend Date―
Financial Position
Hangzhou Tigermed Consulting Co., Ltd. Class H as a current ratio of 2.18, with Debt / Equity ratio of 7.04%
Current Ratio2.18
Quick Ratio2.16
Debt to Market Cap0.03
Net Debt to EBITDA-0.21
Interest Coverage Ratio11.15
Taxes
In the past 12 months, Hangzhou Tigermed Consulting Co., Ltd. Class H has paid 198.16M in taxes.
Income Tax198.16M
Effective Tax Rate0.20
Enterprise Valuation
Hangzhou Tigermed Consulting Co., Ltd. Class H EV to EBITDA ratio is 22.95, with an EV/FCF ratio of 36.07.
EV to Sales4.77
EV to EBITDA22.95
EV to Free Cash Flow36.07
EV to Operating Cash Flow29.15
Balance Sheet
Hangzhou Tigermed Consulting Co., Ltd. Class H has €1.84B in cash and marketable securities with €1.47B in debt, giving a net cash position of €362.28M billion.
Cash & Marketable Securities€1.84B
Total Debt€1.47B
Net Cash€362.28M
Net Cash Per Share€2.94
Tangible Book Value Per Share€23.76
Margins
Gross margin is 27.41%, with operating margin of 14.77%, and net profit margin of 12.99%.
Gross Margin27.41%
Operating Margin14.77%
Pretax Margin14.68%
Net Profit Margin12.99%
EBITDA Margin20.79%
EBIT Margin16.01%
Analyst Forecast
The average price target for Hangzhou Tigermed Consulting Co., Ltd. Class H is €6.10, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target€6.10
Price Target Upside7.08% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast―
EPS Growth Forecast―